ProfileGDS5822 / ILMN_1234427
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 66% 72% 56% 71% 73% 69% 73% 72% 70% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 136.666
GSM1276600PDAC Late Ablation Control 265.172
GSM1276601PDAC Late Ablation Control 327.656
GSM1276602PDAC Late Ablation 151.371
GSM1276603PDAC Late Ablation 27673
GSM1276604PDAC Late Ablation 354.869
GSM1303940PDAC Late Ablation_anti-CTLA4 163.673
GSM1303941PDAC Late Ablation_anti-CTLA4 280.372
GSM1303942PDAC Late Ablation_anti-CTLA4 369.470